Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Novocastra Laboratories was a UK-based developer and manufacturer of antibodies and related reagents for immunohistochemistry and other biomedical research and pathology applications. The company became known for its Novocastra-branded primary antibodies and ancillary staining reagents used in anatomic pathology and laboratory diagnostics. It no longer appears to operate as an independent brand-owner company name, having been renamed Leica Biosystems Newcastle Limited, while the Novocastra brand continues within Leica Biosystems' IHC/ISH product portfolio. Its business focus is therefore best characterized as commercial diagnostics and life science tools rather than therapeutic drug development. The company is healthcare-related, but not a biotech drug pipeline company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Novocastra Laboratories.